Back to search

Article

A clinical and in-silico analysis of hsa-miR-21 and Growth Differentiation factor-15 expression in Diabetic Nephropathy

2021-04-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Diabetic Nephropathy (DN), a microvascular complication, is a major cause of end-stage renal disease (ESRD). GDF-15 and hsa-miR-21 are closely associated with endothelial dysfunction and inflammation.<bold>Methods:</bold> In-silico analysis was used to identify GDF-15 and insulin related protein-protein interaction (PPI) network and a common set of GDF-15 regula...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
333b0746-3bdb-5f8b-a98a-6361a309a6f8
DOI
10.21203/rs.3.rs-396068/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A clinical and in-silico analysis of hsa-miR-21 and Growth Differentiation factor-15 expression in Diabetic NephropathyDOI 10.21203/rs.3.rs-396068/v1
The rs1058587 of growth differentiation factor 15 increased the development and mortality risk of end-stage renal diseaseSemantic proximity
Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney DiseaseSemantic proximity
Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes MellitusSemantic proximity
Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney diseaseSemantic proximity
Correlations between growth differentiation factor 15 (GDF-15) serum levels and gene polymorphism with type 2 diabetes mellitusSemantic proximity
Investigating the role of GDF-15 in diabetes and obesity: A comprehensive analysis of a cohort from the KEDP-studySemantic proximity
Investigate biomarkers and regulatory mechanisms related to RNA modification in diabetic nephropathy through bioinformatics and clinical experimentsSemantic proximity
Growth differentiation factor 15: A novel biomarker with high clinical potentialSemantic proximity
GDF-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysisSemantic proximity
EA15, MIR22, LINC00472 as diagnostic markers for diabetic kidney diseaseSemantic proximity
Identification of diagnostic biomarkers for diabetes nephropathy by multi-chip integrated bioinformatics combining machine-learning strategies and mendelian randomizationSemantic proximity
Association between growth differentiation factor 15 levels and gestational diabetes mellitus: A combined analysisSemantic proximity
Select a neighboring publication to make it the new centre.